Use of these codes has frequently raised concerns for compliance due to a lack of clarity regarding when they’re appropriate.
Subscribe today for full access
to all of these articles.
New study shows that ctDNA liquid biopsy testing after stage II colon cancer may determine whether chemotherapy is required.
The owner, who also owned several telemarketing companies and committed tax evasion of just over $4 million, now faces 14 years in prison.
The companies are working together to explore LabDroid’s capacity to automate sample preparation workflows for long-read sequencing systems.
Move to exclude testimony regarding potential patient impact of lab deficiencies as hearsay is dismissed by the court.
In clinical training sets, the new test allowed SARS-CoV-2 antibodies to be detected using widely available glucometers.
Combined with rising labor costs, COVID-19, and other challenges, stakeholders say the cuts will negatively impact patient care.
The UK-based diagnostics firm received CE marks for a diabetes test, CHF test, as well as an analyzer, and two COVID-19 tests.
Experts offer advice in a recent commentary article on treating patients who may have monkeypox during the current COVID-19 pandemic.
Georgia health system hospitals are the first to be penalized for failing to update their websites or reply to agency warning letters.
A new study suggests that this is a viable idea, particularly in the context of diabetes screening in a Latinx community.
The creation of Global Access Diagnostics aims to expand affordable access to quality tests around the world.
The number of non-COVID-19 tests billed to Medicare during the pandemic has decreased compared to the six-month period before COVID-19.